Target intelligence / Profile preview

Mitochondrial transcription termination factor 2 (MTERF2)

Target
MTERF2
Molecular classification
Transcription factor, Mitochondrial protein, DNA-binding protein
01

Overview

Mitochondrial transcription termination factor 2 (MTERF2) is a nuclear-encoded mitochondrial protein that binds to mitochondrial DNA and plays a regulatory role in the transcription of mitochondrial mRNA and rRNA species. It possesses DNA-binding activity and is primarily located in the mitochondrion. MTERF2 is relatively abundant within mitochondria and is thought to regulate the termination of mitochondrial transcription, influencing mitochondrial genome expression and maintenance. Mutations or alterations in MTERF2 have been associated with specific congenital anomalies and modulate susceptibility to aminoglycoside-induced deafness, but it is not a conventional therapeutic target or drug receptor[1][2][3][7].

Other names
Transcription termination factor 2, mitochondrialMTERF2MTERFD3mTERF2mTERF-likemTERFLFLJ14062mitochondrial transcription termination factor-like proteinmTERF domain-containing protein 3, mitochondrialtranscription termination factor 2, mitochondrialMTERF domain containing 3
02

Biological functions

Regulation of mitochondrial DNA transcriptionTermination of mitochondrial transcriptionDNA bindingMitochondrial RNA and mRNA regulation
03

Disease associations

Linear skin defects with multiple congenital anomalies 1Deafness, aminoglycoside-induced (genetic association)Other (not a primary disease driver but implicated in mitochondrial-related pathologies)

Beyond the preview

Go deeper on Mitochondrial transcription termination factor 2 (MTERF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial transcription termination factor 2 (MTERF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call